Acacia subsidiary receives patents for wireless physiological monitoring technology

Acacia Research Corporation (Nasdaq:ACTG) announced today that a subsidiary has acquired 11 patents for wireless physiological monitoring technology.

“As Acacia's licensing success grows, an increasing number of technology companies are selecting us as their partner for the licensing of their patented technologies”

"As Acacia's licensing success grows, an increasing number of technology companies are selecting us as their partner for the licensing of their patented technologies," commented Paul Ryan, Acacia Chairman and CEO. "Acacia is rapidly becoming the leader in technology licensing and we continue to grow our base of future revenues by adding new patent portfolios," concluded Mr. Ryan.

This patented technology generally relates to the wireless transmission of physiological data such as heart rate and blood pressure. This technology has applications such as monitoring of implantable devices, as well as home healthcare and fitness systems.

Source: Acacia Research Corporation